Lalitha Iyer

Sri International

$1,479,140

Attributed

$1,479,140

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $740.5K · FY2011–19

$1M$750K$500K$250K$0

'11

'12

'13

'14

'15

'16

'17

'18

'19

Funding mix

By agency

NIH$1,479,140 · 4

By mechanism

N01$1,476,417 · 3

N02$2,723 · 1

Top collaborators

No co-investigators on record.

Most similar at Sri International

Same institution · by research overlap

Deborah Bunin$11,920,896
Lawrence R Toll$15,551,699
Debra Burnin$9,670,591
Nurulain T Zaveri$24,519,975
Lalitha Iver$411,035

Others in their field

Top investigators on “Pre-Clinical”

Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
Dennis R. Burton · Scripps Research Institute$257,157,696
Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
Barton F Haynes · Duke University$186,001,832
David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
Reisa A. Sperling · Banner Health$137,047,788

Research focus

Pre-ClinicalToxicologyTumorBiological AvailabilityClinical TrialsContractsPlasmaBaseBiologicalAnalytical MethodTissuesDrug KineticsPharmacodynamicsScheduleRouteResourcesSamplingPreclinical EfficacyCancer TherapyDesignPharmaceutical PreparationsPharmacologic SubstanceLiverIn Vivo